Description
Product Name: | Apolipoprotein C3 Rabbit mAb |
Product Code: | CAB2209 |
Size: | 20uL, 50uL, 100uL |
Synonyms: | APOCIII, HALP2 |
Applications: | WB, IHC, IF |
Reactivity: | Human, Mouse, Rat |
Host Species: | Rabbit |
Immunogen: | A synthesized peptide derived from human Apolipoprotein C3 |
Applications: | WB, IHC, IF |
Recommended Dilutions: | WB 1:500 - 1:2000 IHC 1:50 - 1:200 IF 1:50 - 1:200 |
Reactivity: | Human, Mouse, Rat |
Positive Samples: | Human plasma |
Immunogen: | A synthesized peptide derived from human Apolipoprotein C3 |
Purification Method: | Affinity purification |
Storage: | Store at -20°C. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide, 0.05% BSA, 50% glycerol, pH7.3. |
Isotype: | IgG |
Sequence: | Email for sequence |
Gene ID: | 345 |
Uniprot: | P02656 |
Calculated MW: | 11kDa |
Observed MW: | 11KDa |
UniProt Protein Function: | APOC3: Inhibits lipoprotein lipase and hepatic lipase and decreases the uptake of lymph chylomicrons by hepatic cells. This suggests that it delays the catabolism of triglyceride-rich particles. Defects in APOC3 are the cause of hyperalphalipoproteinemia type 2 (HALP2). HALP2 is a condition characterized by high levels of high density lipoprotein (HDL) and increased HDL cholesterol levels. Belongs to the apolipoprotein C3 family. |
UniProt Protein Details: | Protein type:Secreted, signal peptide; Lipid-binding; Secreted Chromosomal Location of Human Ortholog: 11q23.3 Cellular Component: chylomicron; early endosome; extracellular region; extracellular space Molecular Function:cholesterol binding; enzyme regulator activity; lipase inhibitor activity; phospholipid binding Biological Process: cholesterol efflux; cholesterol homeostasis; G-protein coupled receptor protein signaling pathway; lipoprotein metabolic process; negative regulation of fatty acid biosynthetic process; negative regulation of lipid catabolic process; negative regulation of lipid metabolic process; negative regulation of lipoprotein lipase activity; negative regulation of receptor-mediated endocytosis; phospholipid efflux; regulation of Cdc42 protein signal transduction; retinoid metabolic process; reverse cholesterol transport; triacylglycerol catabolic process; triacylglycerol metabolic process Disease: Apolipoprotein C-iii Deficiency |
NCBI Summary: | Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to delay catabolism of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia. [provided by RefSeq, Jul 2008] |
UniProt Code: | P02656 |
NCBI GenInfo Identifier: | 114026 |
NCBI Gene ID: | 345 |
NCBI Accession: | P02656.1 |
UniProt Secondary Accession: | P02656,Q08E83, Q6Q786, |
UniProt Related Accession: | P02656 |
Molecular Weight: | 10,852 Da |
NCBI Full Name: | Apolipoprotein C-III |
NCBI Synonym Full Names: | apolipoprotein C3 |
NCBI Official Symbol: | APOC3 |
NCBI Official Synonym Symbols: | HALP2; APOCIII |
NCBI Protein Information: | apolipoprotein C-III |
UniProt Protein Name: | Apolipoprotein C-III |
UniProt Synonym Protein Names: | Apolipoprotein C3 |
Protein Family: | Apolipoprotein |
UniProt Gene Name: | APOC3 |
UniProt Entry Name: | APOC3_HUMAN |